Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
The Cooper Companies, Inc.
Type
Public
Traded as NYSE: COO
Industry Medical Devices
Predecessor Martin H. Smith Co., Cooper Tinsley Laboratories, Inc.
Founded 1958 (1958)
Headquarters Pleasanton, California
Area served
Worldwide
Key people
Robert S. Weiss, CEO & Director
Products Contact lenses, medical products and equipment for treating women
Revenue Increase US$1331 million (2011)
Operating income
Increase US$228 million (2011)
Net income
Increase US$175 million (2011)
Total assets Increase US$2625 million (2011)
Total equity Increase US$1937 million (2011)
Number of employees
Increase 7400 (2011)
Divisions CooperVision (CVI), CooperSurgical (CSI)
Website www.coopercos.com

The Cooper Companies, Inc. is a US based, multinational company in the medical specialities sector. With its headquarters in Pleasanton, California, it has over 8,000 employees and consists of two subsidiaries, CooperVision (CVI) that provides contact lenses for both wearers and practitioners, and CooperSurgical (CSI) that provides products for health care professionals and establishments that are involved in women’s health care. Contact lens sales, in particular, soft toric lenses which correct astigmatism, make up for 80% of Cooper Company sales. Cooper Companies, which is publicly traded on the NYSE Euronext (NYSE:COO) recently announced a revenue increase of 9% to $412.0 million for the fiscal third quarter ended July 31, 2013. Cooper Companies has manufacturing facilities in the UK, Puerto Rico and New York and distributes from Rochester, NY, Fareham, UK and Liege, Belgium, among many other smaller distribution locations.

Investment goal date:
Dividends reinvested
The Cooper Companies, Inc. COO report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-03-04
--
--
Q4 2017
2017-12-06
--
--
Q3 2017
2017-08-31
2.6400
2.0900
Q2 2017
2017-06-01
2.5000
2.1200
Q1 2017
2017-03-02
1.9300
1.5300
Q4 2016
2016-12-08
2.2800
1.2300
Q3 2016
2016-09-01
2.3000
1.7900
Q2 2016
2016-06-02
2.0500
1.5200
Q1 2016
2016-03-03
1.8300
1.0500
Q4 2015
2015-12-03
2.0000
0.7500
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
1043401
BlackRock Inc.
3071637
BlackRock Institutional Trust Company, N.A.
1364174
Champlain Investment Partners, LLC
524375
FMR LLC
2602029
FRONTIER CAPITAL MANAGEMENT CO LLC
1042998
GENERATION INVESTMENT MANAGEMENT LLP
1246303
JANUS CAPITAL MANAGEMENT LLC
1743182
NORTHERN TRUST CORP
539329
PIONEER INVESTMENT MANAGEMENT INC
518222
PRICE T ROWE ASSOCIATES INC /MD/
4364521
SCHRODER INVESTMENT MANAGEMENT GROUP
505922
STATE STREET CORP
2492305
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC
629387
Vanguard Group, Inc
4781732
Major Shareholders
Name Relationship
Total Shares
Holding stocks
ROSENBERG STEVEN
0.0300% (12359)
BERK / COO /
KAUFMAN CAROL R
0.0900% (43919)
CHDX / COO / NSP /
WEISS ROBERT S
0.2000% (96611)
ARAY / COO /
PRESS DONALD
0.0900% (43970)
COO /
BENDER A THOMAS
0.0200% (11478)
COO /
RUBENSTEIN ALLAN E
0.0100% (5485)
COO /
PICHOTTA NICHOLAS J
0.0200% (10697)
COO /
WEBER JOHN ARTHUR
0.0300% (15260)
COO /
FOLDEN RODNEY
0.0200% (8592)
COO /
Lindell Jody S
0.0200% (9833)
COO / PDLI /
White Albert G III
0.0700% (35395)
COO /
McBride Daniel G
0.0600% (28395)
COO /
Matz Gregory W
0.0300% (15123)
COO /
Andrews Brian G
0.0100% (2642)
COO /
% ()